Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease
- PMID: 14680319
- DOI: 10.1016/s0094-0143(03)00056-9
Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease
Abstract
Surveillance after surgery for RCC is important because approximately 50% of these patients will develop a disease recurrence, two thirds of who will recur within the first year. Although the prognosis is generally poor in these patients, some may respond favorably to immunotherapy. The small subset of patients who develop solitary metastases has the greatest chance to achieve long-term survival. Aggressive surgical resection is an integral part of this success. Proposed surveillance protocols using a stage-based approach or an integrated approach combining stage with other important prognostic factors attempt to provide a rational approach to identifying treatable recurrences while minimizing unnecessary examinations and patient anxiety. However, strict adherence to follow-up guidelines may not be appropriate for all patients. Factors including patient comorbidities and patient willingness to pursue aggressive management in the event of recurrence may alter the follow-up for each individual.
Similar articles
-
Surveillance following radical or partial nephrectomy for renal cell carcinoma.Curr Urol Rep. 2005 Feb;6(1):7-18. doi: 10.1007/s11934-005-0062-x. Curr Urol Rep. 2005. PMID: 15610692 Review.
-
Renal cell carcinoma: evaluation of the 1997 TNM system and recommendations for follow-up after surgery.Eur Urol. 2001 Jun;39(6):669-74; discussion 675. doi: 10.1159/000052525. Eur Urol. 2001. PMID: 11464056
-
Pattern of metastases in renal cell carcinoma: a single institution study.Indian J Cancer. 2005 Oct-Dec;42(4):173-7. Indian J Cancer. 2005. PMID: 16391434
-
Current aspects of the surgical management of organ-confined, metastatic, and recurrent renal cell cancer.BJU Int. 2005 Oct;96(5):721-7; quiz i-ii. doi: 10.1111/j.1464-410X.2005.05771.x. BJU Int. 2005. PMID: 16144527 Review. No abstract available.
-
Rare locations of metastastatic renal cell carcinoma: a presentation of three cases.Vojnosanit Pregl. 2013 Sep;70(9):881-6. doi: 10.2298/vsp120515014m. Vojnosanit Pregl. 2013. PMID: 24266320
Cited by
-
High-dose interleukin2 - a 10-year single-site experience in the treatment of metastatic renal cell carcinoma: careful selection of patients gives an excellent outcome.J Immunother Cancer. 2016 Oct 18;4:67. doi: 10.1186/s40425-016-0174-5. eCollection 2016. J Immunother Cancer. 2016. PMID: 27777776 Free PMC article.
-
Histone deacetylase 10 suppresses proliferation and invasion by inhibiting the phosphorylation of β-catenin and serves as an independent prognostic factor for human clear cell renal cell carcinoma.Int J Clin Exp Med. 2015 Mar 15;8(3):3734-42. eCollection 2015. Int J Clin Exp Med. 2015. PMID: 26064269 Free PMC article.
-
Increased expression of forkhead box M1 protein is associated with poor prognosis in clear cell renal cell carcinoma.Med Oncol. 2013 Mar;30(1):346. doi: 10.1007/s12032-012-0346-1. Epub 2012 Dec 22. Med Oncol. 2013. PMID: 23263830
-
A Novel Fully-Human Potency-Matched Dual Cytokine-Antibody Fusion Protein Targets Carbonic Anhydrase IX in Renal Cell Carcinomas.Front Oncol. 2019 Nov 13;9:1228. doi: 10.3389/fonc.2019.01228. eCollection 2019. Front Oncol. 2019. PMID: 31799191 Free PMC article.
-
Metastasis of Renal Cell Carcinoma to the Stomach Twenty One Years from Initial Diagnosis.Ulster Med J. 2022 May;91(2):95-97. Epub 2022 Jun 15. Ulster Med J. 2022. PMID: 35722215 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical